Found: 51
Select item for more details and to access through your institution.
Pulmonary coin lesions caused by Dirofilaria immitis.
- Published in:
- Journal of Surgical Oncology, 1990, v. 44, n. 4, p. 268, doi. 10.1002/jso.2930440415
- By:
- Publication type:
- Article
Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 540, doi. 10.1111/dom.15341
- By:
- Publication type:
- Article
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1351, doi. 10.1111/dom.14987
- By:
- Publication type:
- Article
Real‐world outcomes of addition of insulin glargine 300 U/mL (Gla‐300) to glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) therapy in people with type 2 diabetes: The DELIVER‐G study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1617, doi. 10.1111/dom.14739
- By:
- Publication type:
- Article
Dasiglucagon, a next‐generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double‐blind trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2329, doi. 10.1111/dom.14475
- By:
- Publication type:
- Article
A pragmatic randomized clinical trial of insulin glargine 300 U/ mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2004, doi. 10.1111/dom.14152
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 11.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1, doi. 10.1111/dom.14229
- By:
- Publication type:
- Article
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1995, doi. 10.1111/dom.14116
- By:
- Publication type:
- Article
Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2384, doi. 10.1111/dom.13818
- By:
- Publication type:
- Article
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 9, p. 2123, doi. 10.1111/dom.13793
- By:
- Publication type:
- Article
Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real‐world results from the DELIVER Naïve cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1596, doi. 10.1111/dom.13693
- By:
- Publication type:
- Article
Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient‐level pooled analysis of EDITION 1, 2 and 3.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 715, doi. 10.1111/dom.13578
- By:
- Publication type:
- Article
Day‐to‐day fasting self‐monitored blood glucose variability is associated with risk of hypoglycaemia in insulin‐treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 622, doi. 10.1111/dom.13565
- By:
- Publication type:
- Article
Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2148, doi. 10.1111/dom.13345
- By:
- Publication type:
- Article
Real‐world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1293, doi. 10.1111/dom.13199
- By:
- Publication type:
- Article
Clinical outcomes in high‐hypoglycaemia‐risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first‐generation basal insulin analogue in the United States : Results from the DELIVER High Risk real‐world study
- Published in:
- Endocrinology, Diabetes & Metabolism, 2022, v. 5, n. 1, p. 1, doi. 10.1002/edm2.306
- By:
- Publication type:
- Article
Clinical Efficacy of Once-weekly Glucagonlike Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study.
- Published in:
- Diabetes Spectrum, 2021, v. 34, n. 4, p. 407, doi. 10.2337/ds20-0079
- By:
- Publication type:
- Article
Combination therapy for NIDDM with biosynthetic human insulin and glyburide.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Combination Therapy With Insulin and Sulfonylureas for Type II Diabetes.
- Published in:
- Diabetes Care, 1990, v. 13, n. 6, p. 687, doi. 10.2337/diacare.13.6.687
- By:
- Publication type:
- Article
How to communicate home blood glucose monitoring data more effectively: A 'low-tech' fax solution to a common diabetes data management dilemma.
- Published in:
- Clinical Diabetes, 1999, v. 17, n. 2, p. 85
- By:
- Publication type:
- Article
Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal‐bolus insulin regimens in treat‐to‐target trials: A narrative review.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 7, p. 1, doi. 10.1111/dme.15339
- By:
- Publication type:
- Article
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.
- Published in:
- Journal of Diabetes, 2018, v. 10, n. 2, p. 94, doi. 10.1111/1753-0407.12576
- By:
- Publication type:
- Article
Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second-generation basal insulin analogues.
- Published in:
- 2020
- By:
- Publication type:
- Journal Article
Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 5, p. 883, doi. 10.1007/s13300-023-01400-w
- By:
- Publication type:
- Article
Synthesis and X-ray Structural Studies of a Substituted 2,3,4,5-Tetrahydro-1H-3-benzazonine and a 1,2,3,5-Tetrahydro-4,3-benzoxazonine.
- Published in:
- Molecules, 2015, v. 20, n. 1, p. 487, doi. 10.3390/molecules20010487
- By:
- Publication type:
- Article
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections.
- Published in:
- 2017
- By:
- Publication type:
- journal article
346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-346-P
- By:
- Publication type:
- Article
345-P: The Next Generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery from Hypoglycemia across Subgroups.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-345-P
- By:
- Publication type:
- Article
344-P: Integrated Safety Analysis of Dasiglucagon for Treatment of Severe Hypoglycemia.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-344-P
- By:
- Publication type:
- Article
236-OR: Volagidemab, a Human Glucagon Receptor Antagonist, Improves Glycemic Control in Subjects with Type 1 Diabetes (T1D): A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-236-OR
- By:
- Publication type:
- Article
149-OR: Evaluation of the Next Generation 180-Day Long-Term Implantable Eversense CGM System: PROMISE Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-149-OR
- By:
- Publication type:
- Article
137-OR: Dasiglucagon Ready-to-Use Autoinjector Is More Reliably and Quickly Administered than Glucagon Emergency Kit (GEK).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-137-OR
- By:
- Publication type:
- Article
750-P: Afinion HbA1c Dx Point-of-Care Test Is Accurate to Diagnose Diabetes in CLIA-Waived Settings.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-750-P
- By:
- Publication type:
- Article
105-LB: Real-World Outcomes of Addition of Insulin Glargine 300 U/mL (Gla-300) to GLP-1RA Therapy in People with Type 2 Diabetes (PWD2): The DELIVER-G Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-105-LB
- By:
- Publication type:
- Article
101-LB: Reported Satisfaction during the Medtronic Extended-Wear Infusion Set (EWIS) Pivotal Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-101-LB
- By:
- Publication type:
- Article
100-LB: Infusion Set Survival and Performance during the Medtronic Extended-Wear Infusion Set (EWIS) Pivotal Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-100-LB
- By:
- Publication type:
- Article
180-OR: Dasiglucagon as a Fast and Effective Treatment for Severe Hypoglycemia in Children with Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-180-OR
- By:
- Publication type:
- Article
1053-P: Dasiglucagon Hypopal Autoinjector as a Fast and Effective Treatment for Severe Hypoglycemia: Results of a Phase 3 Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1053-P
- By:
- Publication type:
- Article
133-LB: High Hypoglycemia Risk Patients with T2D on First-Generation Basal Insulins (BI) in the U.S. Have a Lower Risk of Hypoglycemia after One Year following Switch to Insulin Glargine 300 U/mL (Gla-300) vs. First-Generation BIs (DELIVER - High Risk).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-133-LB
- By:
- Publication type:
- Article
910-P: Improved Accuracy of 14-Day Factory-Calibrated FreeStyle Libre System with New Glucose Algorithm.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-910-P
- By:
- Publication type:
- Article
1106-P: Predictive Modeling Suggests Subgroup Effects for Severe Hypoglycemia in T2DM Patients Treated with Gla-300 vs. IDeg: The LIGHTNING Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1106-P
- By:
- Publication type:
- Article
1095-P: Early Hypoglycemia after Initiation of Second-Generation Basal Insulin (BI) Analogs: Patient Characteristics and Clinical Outcomes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1095-P
- By:
- Publication type:
- Article
1087-P: A Randomized Pragmatic Real-World Clinical Trial Comparing Insulin Glargine 300 U/mL (Gla-300) with Standard of Care First-Generation Basal Insulins (SoC-BIs) in Insulin-Naïve Patients with Type 2 Diabetes: Twelve-Month Analysis of the ACHIEVE Control Study
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1087-P
- By:
- Publication type:
- Article